Back to Journals » Blood and Lymphatic Cancer: Targets and Therapy

Blood and Lymphatic Cancer: Targets and Therapy


Journal Articles:

- 67 records -

Plasmablastic lymphoma: current perspectives

Lopez A, Abrisqueta P

Blood and Lymphatic Cancer: Targets and Therapy 2018, 8:63-70

Published Date: 4 October 2018

Outcomes and relapse patterns following chemotherapy in advanced Hodgkin lymphoma in the positron emission tomography era

Lapuz C, Enjeti AK, O'Brien PC, Capp AL, Holliday EG, Gupta SA

Blood and Lymphatic Cancer: Targets and Therapy 2018, 8:13-20

Published Date: 18 April 2018

Blastic plasmacytoid dendritic cell neoplasm: challenges and future prospects

Trottier AM, Cerquozzi S, Owen CJ

Blood and Lymphatic Cancer: Targets and Therapy 2017, 7:85-93

Published Date: 11 December 2017

Clinical potential of midostaurin in advanced systemic mastocytosis

Chandesris MO, Damaj G, Lortholary O, Hermine O

Blood and Lymphatic Cancer: Targets and Therapy 2017, 7:25-35

Published Date: 3 May 2017

Uptake of lymphoma-derived exosomes by peripheral blood leukocytes

Ferguson Bennit HR, Gonda A, Oppegard LJ, Chi DP, Khan S, Wall NR

Blood and Lymphatic Cancer: Targets and Therapy 2017, 7:9-23

Published Date: 28 February 2017

MYC as therapeutic target in leukemia and lymphoma

Cortiguera MG, Batlle-López A, Albajar M, Delgado MD, León J

Blood and Lymphatic Cancer: Targets and Therapy 2015, 5:75-91

Published Date: 22 July 2015

IL-15 as a potential target in leukemia

Xiong Y, Bensoussan D, Decot V

Blood and Lymphatic Cancer: Targets and Therapy 2015, 5:55-63

Published Date: 9 April 2015

Targeting CD20 in chronic lymphocytic leukemia

Nahas MR, Arnason JE

Blood and Lymphatic Cancer: Targets and Therapy 2015, 5:43-53

Published Date: 10 March 2015

Emerging role of SOX11 in mantle cell lymphoma

Kuci V, Nordström L, Jerkeman M, Ek S

Blood and Lymphatic Cancer: Targets and Therapy 2015, 5:35-42

Published Date: 27 February 2015

MicroRNAs as B-cell lymphoma biomarkers

Manterola L, Fernandez-Mercado M, Larrea E, Goicoechea I, Arestin M, Armesto M, Hernandez L, Lawrie CH

Blood and Lymphatic Cancer: Targets and Therapy 2015, 5:25-34

Published Date: 4 February 2015

Multiple myeloma: optimal management and long-term disease control

Sriskandarajah P, Davies FE

Blood and Lymphatic Cancer: Targets and Therapy 2014, 4:121-134

Published Date: 6 November 2014

Optimal management of endemic Burkitt lymphoma: a holistic approach mindful of limited resources

Moormann AM, Skiles JL, Otieno JA, Buckle GC, Vik TA

Blood and Lymphatic Cancer: Targets and Therapy 2014, 4:91-99

Published Date: 23 September 2014

Developments in anaplastic large-cell lymphoma: targeting the anaplastic lymphoma kinase

Farina F, Stasia A, Gambacorti-Passerini C

Blood and Lymphatic Cancer: Targets and Therapy 2014, 4:69-79

Published Date: 21 August 2014

Emerging targets in human lymphoma: targeting the MYD88 mutation

Wang JQ, Jeelall YS, Horikawa K

Blood and Lymphatic Cancer: Targets and Therapy 2013, 3:53-61

Published Date: 13 August 2013

Ruxolitinib as an emerging treatment in myelofibrosis

Emanuel RM, Geyer HL, Mesa RA

Blood and Lymphatic Cancer: Targets and Therapy 2013, 3:11-18

Published Date: 9 March 2013

Therapeutic developments in acute lymphoblastic leukemia

MacKenzie A, Kasner M

Blood and Lymphatic Cancer: Targets and Therapy 2012, 2:145-158

Published Date: 27 November 2012

Recent developments in myelofibrosis

Tibes R, Bogenberger JM, Mesa RA

Blood and Lymphatic Cancer: Targets and Therapy 2012, 2:125-136

Published Date: 2 July 2012

Advances in the diagnosis and management of lymphoma

Word ZH, Matasar MJ

Blood and Lymphatic Cancer: Targets and Therapy 2012, 2:29-55

Published Date: 3 February 2012

The evaluation and optimal use of rituximab in lymphoid malignancies

Robak T, Robak P, Smolewski P

Blood and Lymphatic Cancer: Targets and Therapy 2012, 2:1-16

Published Date: 4 January 2012

Reduced intensity treatment in early-stage Hodgkin’s lymphoma

Prodduturi P, Armitage JO

Blood and Lymphatic Cancer: Targets and Therapy 2011, 1:23-31

Published Date: 25 November 2011

mTOR inhibitor in the treatment of Hodgkin’s lymphoma: a case report

Ibeas P, Cantos B, Provencio M.

Blood and Lymphatic Cancer: Targets and Therapy 2011, 1:19-22

Published Date: 8 November 2011

Mantle cell leukemia as a cause of leukostasis

Smith D, Cable C, Chisholm C, Linz W, Koss W, Dobin S, Rappaport E

Blood and Lymphatic Cancer: Targets and Therapy 2011, 1:5-8

Published Date: 28 April 2011